Systems Toxicology of Male Reproductive Development: Profiling 774 Chemicals for Molecular Targets and Adverse

Maxwell C K Leung1, Jimmy Phuong, Nancy C Baker

  • 1Oak Ridge Institute for Science and Education, Oak Ridge, Tennessee.

Abstract

Insights

Environmental chemicals are linked to male reproductive health issues. This study identified 774 chemicals and their molecular targets, revealing a hierarchy of adverse outcomes consistent with the testicular dysgenesis syndrome (TDS) hypothesis.

Area of Science:

  • Environmental toxicology
  • Reproductive toxicology
  • Computational toxicology

Background:

  • Male reproductive health issues like testicular cancer and low semen quality are rising.
  • Prenatal exposure to environmental chemicals is a suspected cause, supported by human and animal studies.

Purpose of the Study:

  • To identify correlations between environmental chemicals, molecular targets, and adverse male reproductive outcomes.
  • To investigate the developmental toxicity of the male reproductive system across a wide range of chemicals.

Main Methods:

  • Utilized the U.S. EPA's ToxRefDB animal study database and literature analysis to select 774 chemicals.
  • Employed U.S. EPA's ToxCastDB high-throughput screening database to profile chemical bioactivity against ~800 molecular and cellular features.

Main Results:

  • Observed a phenotypic hierarchy of testicular atrophy, sperm effects, tumors, and malformations in 281 chemicals, aligning with the testicular dysgenesis syndrome (TDS) hypothesis.
  • Identified 54 chemicals with male developmental effects, linking them to 156 gene annotations in a network.

Conclusions:

  • Computational modeling confirmed a phenotypic hierarchy consistent with the TDS hypothesis.
  • Confirmed roles of estrogen and androgen pathways, and identified new targets including retinoic acid signaling, vascular remodeling proteins, GPCRs, and cytochrome P450s.

Related Concept Videos

Toxicity Testing in Animals01:23

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
133
Toxic Reactions: Overview01:26

Toxic Reactions: Overview

When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
3.8K
Types of Toxins01:36

Types of Toxins

Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
4.0K
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
2.1K
Toxicokinetics: Overview01:21

Toxicokinetics: Overview

Studies that assess how a drug is absorbed, distributed, metabolized, and excreted (ADME) at toxic doses are termed toxicokinetics. Understanding toxicokinetics helps predict adverse drug reactions (ADRs) and manage toxicity in humans.Toxicokinetics differs from pharmacokinetics mainly in the dose levels studied, with toxicokinetics focusing on higher toxic doses. The kinetics at these levels can be non-linear due to altered physiological processes. Toxicodynamics examines the relationship...
151
Bioactivation and Tissue Toxicity01:25

Bioactivation and Tissue Toxicity

Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...
108